| |
| |
|
| Insider
Information: |
Larosa Joseph J |
| Relationship: |
EVP General Counsel an... |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,543 |
|
|
Indirect Shares
|
3,722 |
|
|
| Direct
Value |
$35,701,049 |
|
|
|
Indirect Value
|
$3,636,245 |
|
|
| Total
Shares |
40,265 |
|
|
| Total
Value |
$39,337,294 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -17.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP General Counsel an... |
2024-02-26 |
36,543 |
2024-02-26 |
3,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
SVP Gen Counsel & Secretary |
• – – |
2011-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,625 |
14,438 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,930 |
16,368 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,338 |
16,520 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,752 |
23,110 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2023-03-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,006 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,133 |
30,705 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
• – – |
2015-09-01 |
4 |
OE |
$59.20 |
$99,989 |
D/D |
1,689 |
16,756 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
• – – |
2015-03-25 |
4 |
OE |
$59.20 |
$183,342 |
D/D |
3,097 |
15,067 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-04-14 |
4 |
OE |
$59.20 |
$296,000 |
D/D |
5,000 |
19,438 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-04-16 |
4 |
OE |
$59.20 |
$296,000 |
D/D |
5,000 |
19,438 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2022-12-09 |
4 |
D |
$753.28 |
$370,614 |
D/D |
(492) |
20,358 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2021-12-11 |
4 |
D |
$664.34 |
$463,045 |
D/D |
(697) |
26,051 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-08-27 |
4 |
OE |
$52.03 |
$520,300 |
D/D |
10,000 |
21,241 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2023-12-11 |
4 |
D |
$844.09 |
$564,696 |
D/D |
(669) |
30,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-04-17 |
4 |
OE |
$59.20 |
$688,022 |
D/D |
11,622 |
22,458 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2023-12-08 |
4 |
D |
$843.79 |
$718,909 |
D/D |
(852) |
28,572 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-04-01 |
4 |
OE |
$59.20 |
$888,000 |
D/D |
15,000 |
23,924 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2024-02-07 |
4 |
S |
$950.00 |
$950,000 |
D/D |
(1,000) |
38,543 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2024-02-22 |
4 |
S |
$967.65 |
$967,650 |
D/D |
(1,000) |
37,543 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2024-02-26 |
4 |
S |
$990.00 |
$990,000 |
D/D |
(1,000) |
36,543 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-04-20 |
4 |
AS |
$567.30 |
$1,013,985 |
D/D |
(1,778) |
14,438 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-05-14 |
4 |
OE |
$59.20 |
$1,084,011 |
D/D |
18,311 |
32,749 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
• – – |
2020-04-15 |
4 |
AS |
$514.63 |
$1,172,187 |
D/D |
(2,262) |
14,438 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
• – – |
2015-03-16 |
4 |
OE |
$59.20 |
$1,200,635 |
D/D |
20,281 |
11,970 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
